Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vaccitech
Vaccitech
Vaccitech reemerges as Barinthus with hep B data showing declines in infection levels
Vaccitech reemerges as Barinthus with hep B data showing declines in infection levels
Fierce Biotech
Barinthus Biotherapeutics
Vaccitech
clinical trials
hepatitis B
Flag link:
Vaccitech’s chronic Hepatitis B drug sees positive topline data
Vaccitech’s chronic Hepatitis B drug sees positive topline data
Clinical Trials Arena
Vaccitech
VTP-300
clinical trials
hepatitis B
Flag link:
UK biotech ‘booming’ as sector rakes in £1.6bn in Q2 financing
UK biotech ‘booming’ as sector rakes in £1.6bn in Q2 financing
Pharmaforum
UK
biotech
Centessa
Achilles Therapeutics
Vaccitech
Exscientia
Oxford Nanopore
Gyroscope Therapeutics
Flag link:
Biotech IPO wave rolls on as Werewolf, Vaccitech raise $230M for clinical trials
Biotech IPO wave rolls on as Werewolf, Vaccitech raise $230M for clinical trials
MedCity News
Werewolf Therapeutics
Vaccitech
IPOs
cancer immunotherapy
vaccines
Flag link:
Vaccitech confidentially files for Nasdaq IPO
Vaccitech confidentially files for Nasdaq IPO
Endpoints
Vaccitech
IPOs
NASDAQ
COVID-19
vaccines
Flag link:
Oxford vaccines spinout Vaccitech raises $168M, laying groundwork for an IPO
Oxford vaccines spinout Vaccitech raises $168M, laying groundwork for an IPO
MedCity News
University of Oxford
spinoffs
Vaccitech
vaccines
IPOs
Flag link:
COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO
COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO
Fierce Biotech
Vaccitech
Pfizer
Kite Pharma
vaccines
AstraZeneca
Flag link:
Biotech behind AstraZeneca's COVID-19 vaccine advances next-gen prospect
Biotech behind AstraZeneca's COVID-19 vaccine advances next-gen prospect
Fierce Biotech
Vaccitech
AstraZeneca
vaccines
UK
COVID-19
Flag link:
Google backs $27M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab
Google backs $27M launch round for Holy Grail R&D work on two targets: a cancer vaccine and a universal flu jab
Endpoints
Google
R&D
flu vaccines
Vaccitech
vaccines
cancer vaccines
Flag link: